Alaunos Therapeutics, Inc. (TCRT) vs Vivos Therapeutics, Inc. (VVOS)
A side-by-side comparison of Alaunos Therapeutics, Inc. and Vivos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
TCRT
Alaunos Therapeutics, Inc.
$0.73HealthcareDelayed quote: Oct 6, 2026, 3:03 PM EDT
VVOS
Vivos Therapeutics, Inc.
$0.16HealthcareDelayed quote: Oct 6, 2026, 3:03 PM EDT
Total return — TCRT vs VVOS
growth of $100 · dividends reinvested · last 6yTCRT -99.8% (-64.8%/yr)VVOS -99.9% (-70.3%/yr)TCRT compounded faster over this window
TCRT VVOS
TCRT vs VVOS: by the numbers
- •VVOS is the larger company ($2M vs $2M market cap).
- •Both run net losses; VVOS's is the smaller (-122.42% vs -133666.67% net margin).
Metrics side by side
Valuation
| Metric | TCRT | VVOS |
|---|---|---|
| P/S ratio | 595.80 | 0.10 |
| P/B ratio | 2.74 | N/A |
Profitability
| Metric | TCRT | VVOS |
|---|---|---|
| Gross margin | -27160.00% | 59.72% |
| Operating margin | -84500.00% | -107.92% |
| Net margin | -133666.67% | -122.42% |
| ROE | -615.03% | N/A |
| ROIC | -622.39% | -182.30% |
Growth (annualized)
| Metric | TCRT | VVOS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.52% |
| Total return CAGR (5Y) | -69.13% | -72.60% |
Frequently asked
- How have TCRT and VVOS total returns compared?
- Over the past 5 years, TCRT delivered -69.13% and VVOS delivered -72.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.